{"id":71477,"date":"2026-05-20T10:00:00","date_gmt":"2026-05-20T10:00:00","guid":{"rendered":"https:\/\/medsbase.com\/hexarelin-acetate\/"},"modified":"2026-05-21T07:14:09","modified_gmt":"2026-05-21T07:14:09","slug":"hexarelin-acetate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/hexarelin-acetate\/","title":{"rendered":"Hexarelin Acetaat (Examorelin)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is Hexarelin Acetate?<\/h3>\n<p style=\"margin: 0;\"><strong>Hexarelin Acetate<\/strong> (also called <strong>Examorelin<\/strong>) is a synthetic 6-amino-acid <strong>growth hormone secretagogue (GHS)<\/strong>: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub>, with the bioactive acetate salt counterion. CAS 140703-51-1 (free peptide) \/ 171263-26-6 (acetate salt). MW 887.04 free \/ 947.07 g\/mol as acetate. The most potent ghrelin mimetic in the GHRP-2 \/ GHRP-6 \/ Ipamorelin family \u2014 strongly activates GHSR-1a on pituitary somatotrophs and on cardiomyocytes (the latter via CD36 receptor for cardioprotective effects independent of GH release). Drives strong GH pulsatile release without acute hunger increase, but with documented cortisol and prolactin elevation at higher doses. For laboratory research use only. <em>Synthetic peptide \u2014 not natural ghrelin.<\/em><\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Wat u krijgt bij MedsBase:<\/strong> Lyophilized \u226599% HPLC-verified Hexarelin Acetate \u00b7 COA available on request \u00b7 Discreet temperature-stable packaging \u00b7 Worldwide research-supply courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specificatie<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Compound Class<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Synthetic 6-aa peptide growth hormone secretagogue (GHRP family); ghrelin mimetic; acetate salt<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Chemical Name<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Hexarelin Acetate (synonyms: Examorelin, EP-23905, MF6003)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">140703-51-1 (free peptide); 171263-26-6 (acetate salt)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">L-His-D-2-methyl-Trp-L-Ala-L-Trp-D-Phe-L-Lys-NH<sub>2<\/sub> (6 amino acids; D-2-Me-Trp at position 2 and D-Phe at position 5 confer proteolytic stability and receptor selectivity; C-terminal amide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Molecular Formula \/ MW<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>47<\/sub>H<sub>58<\/sub>N<sub>12<\/sub>O<sub>6<\/sub> (free peptide, MW 887.04 g\/mol); + C<sub>2<\/sub>H<sub>4<\/sub>O<sub>2<\/sub> acetate counterion (acetate salt, MW 947.07 g\/mol)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Werkingsmechanisme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Dual-receptor pharmacology. (1) Primary: agonist at <strong>GHSR-1a<\/strong> (growth-hormone-secretagogue receptor type 1a, the ghrelin receptor) on pituitary somatotrophs \u2014 drives strong pulsatile GH release via Gq-PLC-IP<sub>3<\/sub>-Ca<sup>2+<\/sup> signalling; also engages GHSR on arcuate-nucleus neurons. (2) Secondary: binds <strong>CD36<\/strong> (a scavenger receptor) on cardiomyocytes, vascular endothelium, and macrophages \u2014 produces cardioprotective effects in ischaemia-reperfusion models <em>independent<\/em> of GH release. The dual mechanism is unique to Hexarelin among the GHRP family.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Potency vs Family<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Most potent GH-releasing peptide in the GHRP-2 \/ GHRP-6 \/ Hexarelin \/ Ipamorelin family on a per-mg basis \u2014 but with corresponding cortisol and prolactin elevation at higher doses (in contrast to <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a>, which produces clean GH-only release).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white powder; single-use research vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Zuiverheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Opslag<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized: 2\u20138 \u00b0C short-term; \u221220 \u00b0C long-term (\u226536 months). Reconstituted: 2\u20138 \u00b0C, use within 30 days. Avoid repeated freeze-thaw.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Onderzoeksgebruik<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">For laboratory research use only. Not for human or veterinary diagnostic or therapeutic use. Hexarelin \/ Examorelin is on the WADA Prohibited List (class S2, Peptide Hormones and Growth Factors) and is prohibited at all times in athletic contexts.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Mechanism of Action \u2014 Dual GHSR-1a + CD36 Pharmacology<\/h2>\n<p>Hexarelin is unique among the GHRP family in having well-documented activity at two mechanistically distinct receptors:<\/p>\n<ul>\n<li><strong>GHSR-1a agonism (primary GH-releasing mechanism)<\/strong> \u2014 Hexarelin binds the ghrelin receptor (GHSR-1a, a Gq-coupled GPCR) on pituitary somatotrophs with sub-nanomolar affinity. Receptor activation drives PLC \u2192 IP<sub>3<\/sub> \u2192 Ca<sup>2+<\/sup> release, triggering GH secretory granule exocytosis. The D-2-Me-Trp at position 2 and D-Phe at position 5 confer high resistance to proteolytic degradation, extending the plasma half-life vs natural ghrelin.<\/li>\n<li><strong>CD36 binding (secondary cardioprotective mechanism)<\/strong> \u2014 Hexarelin (unlike Ipamorelin or GHRP-6 to the same degree) binds CD36 \u2014 a scavenger receptor on cardiomyocytes, vascular endothelium, and macrophages. Published research (Bodart et al. 2002, others) has demonstrated direct cardioprotective effects in ischaemia-reperfusion injury models that are independent of growth hormone \u2014 the CD36-binding mechanism preserves cardiac contractility, reduces post-ischaemic ventricular dysfunction, and modulates macrophage activation.<\/li>\n<li><strong>GH-axis downstream consequences<\/strong> \u2014 Like all GHRPs, Hexarelin&#8217;s GH-releasing activity drives downstream IGF-1 production, increased lipolysis, increased lean mass, and improved nitrogen balance in published in-vivo work. Effects largely mirror the broader GH-axis pharmacology.<\/li>\n<li><strong>Tachyphylaxis with chronic dosing<\/strong> \u2014 Sustained high-dose Hexarelin produces GHSR-1a desensitization (tachyphylaxis), reducing GH-releasing potency over 4\u20136 weeks of continuous administration. Published research uses pulsed dosing protocols to mitigate this.<\/li>\n<li><strong>Cortisol and prolactin elevation<\/strong> \u2014 At higher doses Hexarelin elevates serum cortisol and prolactin alongside GH (mirroring GHRP-2 and GHRP-6 in this respect). For research protocols where clean GH-only release is needed, <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> is the preferred selective alternative.<\/li>\n<\/ul>\n<h2>Gepubliceerde onderzoeksapplicaties<\/h2>\n<ul>\n<li><strong>GHRP \/ GH-secretagogue pharmacology<\/strong> \u2014 most potent GHRP reference compound on a per-mg basis<\/li>\n<li><strong>GHSR-1a receptor pharmacology<\/strong> \u2014 canonical research tool alongside ghrelin and ipamorelin<\/li>\n<li><strong>Cardioprotection research (CD36-dependent)<\/strong> \u2014 unique among the GHRP family for documented direct cardiac effects in ischaemia-reperfusion models<\/li>\n<li><strong>Growth-hormone axis research<\/strong> \u2014 drives strong endogenous GH pulse without injecting exogenous hGH<\/li>\n<li><strong>Body-composition research<\/strong> \u2014 used in published rodent work alongside GHRH analogues for lean-mass \/ fat-mass dissection<\/li>\n<li><strong>Tachyphylaxis and GHSR-1a desensitization research<\/strong> \u2014 well-documented tachyphylaxis profile makes it a useful tool for receptor-desensitization pharmacology<\/li>\n<\/ul>\n<p>For broader context see <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> (clean GH-only secretagogue \u2014 no cortisol\/prolactin), <a href=\"https:\/\/medsbase.com\/nl\/ghrp-2-acetate\/\">GHRP-2 Acetaat<\/a> (sibling GHS), <a href=\"https:\/\/medsbase.com\/nl\/ghrp-6-acetate\/\">GHRP-6 Acetaat<\/a> (sibling GHS), <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a> (GHRH analogue, commonly stacked), <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> (GHRH 1-29).<\/p>\n<h2>Available Strengths<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px;\">Vulsterkte<\/th>\n<th style=\"padding: 10px;\">Verpakkingsgroottes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong> \u2014 entry research protocols, dose-titration work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong> \u2014 standard research protocols, multi-cohort sample sizes; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>How It Compares \u2014 Hexarelin vs Ipamorelin<\/h2>\n<p><a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> is the cleanest GH-only secretagogue in this family \u2014 strong GH release with no cortisol or prolactin elevation. Hexarelin is the most potent in the family on a per-mg basis but elevates cortisol and prolactin at higher doses. Hexarelin also has the unique CD36-binding cardioprotective mechanism. Researchers choose Hexarelin for maximum GH-releasing potency or for the CD36 axis specifically; Ipamorelin for clean isolated GH-axis research where avoiding cortisol \/ prolactin confounders matters.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px;\">Criterium<\/th>\n<th style=\"padding: 10px;\">Hexarelin<\/th>\n<th style=\"padding: 10px;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>MW<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">887 \/ 947 (acetate)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">711.85<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>GH-release potency<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Highest in family (per mg)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Strong but less potent than Hexarelin<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cortisol \/ prolactin<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Elevated at higher doses<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No documented elevation \u2014 clean<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>CD36 binding<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Yes \u2014 cardioprotective<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minimal \/ not documented<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Beste voor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Max-potency GH research, cardioprotection<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Clean GH-only research, no-confounder protocols<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Need BAC water?<\/strong> Reconstituting any lyophilized vial requires sterile bacteriostatic water. Pair this product with our <a href=\"\/nl\/bac-water\/\"><strong>BAC Water (Bacteriostatisch Water)<\/strong><\/a> \u2014 30 mL multi-dose vial, 0.9% benzyl-alcohol-preserved, USP-grade.<\/div>\n<h2>Opslag en Reconstituering<\/h2>\n<p>Store lyophilized vials at 2\u20138 \u00b0C; freeze unopened vials at \u221220 \u00b0C for long-term storage. Reconstitute with bacteriostatic water (1.0 mL per 2 mg vial \u2192 2 mg\/mL; 1.0 mL per 5 mg vial \u2192 5 mg\/mL). Swirl gently to dissolve. Store reconstituted vials at 2\u20138 \u00b0C, use within 30 days. Protect from light. Avoid repeated freeze-thaw cycles.<\/p>\n<h2>FAQ<\/h2>\n<h3>How is Hexarelin different from GHRP-2 and GHRP-6?<\/h3>\n<p>All three are 6-amino-acid synthetic GH-releasing peptides in the same family. Hexarelin is the most potent per-mg, but also elevates cortisol\/prolactin more than GHRP-2 and less than GHRP-6. Hexarelin uniquely binds CD36 for cardioprotective effects not seen with GHRP-2 or GHRP-6.<\/p>\n<h3>What is the typical research dose?<\/h3>\n<p>Rodent in-vivo protocols typically use 50\u2013200 \u00b5g\/kg SC, 1\u20133\u00d7\/day. In-vitro pituitary culture protocols use nanomolar concentrations. Published human research has used 1\u20132 mg SC per dose.<\/p>\n<h3>What is the WADA status?<\/h3>\n<p>Hexarelin (Examorelin) is on the WADA Prohibited List under class S2 (Peptide Hormones, Growth Factors). Prohibited at all times in athletic contexts.<\/p>\n<h3>Can Hexarelin be combined with CJC-1295 or other GHRH analogues?<\/h3>\n<p>Yes \u2014 Hexarelin (GHS) + CJC-1295 (GHRH analogue) is the canonical &#8220;GHRP + GHRH&#8221; stacking protocol that produces synergistic GH release through engagement of two complementary pituitary pathways. Sermorelin and Tesamorelin are alternative GHRH partners.<\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order research compounds from MedsBase:<\/strong> Lyophilized HPLC \u226599% peptides &amp; compounds \u00b7 COA available on request \u00b7 Discreet temperature-stable packaging \u00b7 Worldwide courier \u00b7 <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> on every order \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Research Peptides for Growth-Hormone Axis Research<\/h2>\n<ul>\n<li><a href=\"\/nl\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Clean GH-only secretagogue \u2014 no cortisol\/prolactin elevation<\/li>\n<li><a href=\"\/nl\/ghrp-2-acetate\/\"><strong>GHRP-2 Acetaat<\/strong><\/a> \u2014 Sibling GHRP family member<\/li>\n<li><a href=\"\/nl\/ghrp-6-acetate\/\"><strong>GHRP-6 Acetaat<\/strong><\/a> \u2014 Sibling GHRP family member (also increases hunger)<\/li>\n<li><a href=\"\/nl\/cjc-1295-with-dac\/\"><strong>CJC-1295 met DAC<\/strong><\/a> \u2014 GHRH analogue \u2014 canonical stacking partner<\/li>\n<li><a href=\"\/nl\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 GHRH 1-29 analogue \u2014 alternative GHRH partner<\/li>\n<li><a href=\"\/nl\/bac-water\/\"><strong>BAC Water (Bacteriostatisch Water)<\/strong><\/a> \u2014 Required for reconstituting any lyophilized vial \u2014 sterile, 0.9% benzyl-alcohol-preserved diluent<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Most potent GHRP-family growth hormone secretagogue per-mg<br \/>\n\u2705 Dual mechanism \u2014 GHSR-1a (GH release) + CD36 (cardioprotection)<br \/>\n\u2705 Synthetic 6-aa peptide; D-2-Me-Trp + D-Phe modifications for stability<br \/>\n\u2705 Strong GH release with documented cortisol\/prolactin elevation at higher doses<br \/>\n\u2705 CAS 140703-51-1 (free) \/ 171263-26-6 (acetate); MW 887.04 \/ 947.07<\/p>\n<p><strong>Hexarelin Acetate<\/strong> contains synthetic 6-aa research peptide.<\/p>","protected":false},"featured_media":71522,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6525,6521,6523,6522,6524,6520,6494],"class_list":{"0":"post-71477","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-cd36-cardioprotection","8":"product_tag-examorelin","9":"product_tag-gh-secretagogue","10":"product_tag-ghrp-family","11":"product_tag-ghsr-1a-agonist","12":"product_tag-hexarelin","13":"product_tag-research-peptide","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/71477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=71477"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/71522"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=71477"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=71477"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=71477"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=71477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}